BioXcel Therapeutics, Inc.
- BTAI
- NASDAQ
- Biotechnology
- AI Drug Discovery
- Neuroscience
- Immuno-Oncology
$0.07
Today +64.22%Quote Sep 4, 2026, 08:00 PM UTC
−94.36%over the last month
Max drawdown −95.6%From 1-month high −94.4%3 months −96.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative therapies in the fields of neuroscience and immuno-oncology.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
29
Market value
$902,171.2
Approximate share count
Floor
$0.07
9.1% below price
Price vs analyst targets
15 analysts
Lowest target
$1.00Highest target
$25.00
$1.00Highest target
$25.00
- Price $0.07
- Average target $12.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 16138% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BTAIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free